272 related articles for article (PubMed ID: 28669104)
61. Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre.
Gorgel SN; Akin Y; Koc EM; Kose O; Ozcan S; Yilmaz Y
Int Urol Nephrol; 2020 Mar; 52(3):469-473. PubMed ID: 31659597
[TBL] [Abstract][Full Text] [Related]
62. The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Scheipner L; Smolle MA; Barth D; Posch F; Stotz M; Pichler M; StÖger H; Gerger A; Riedl JM
Anticancer Res; 2021 Jan; 41(1):429-436. PubMed ID: 33419840
[TBL] [Abstract][Full Text] [Related]
63. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
Hermans TJ; Fransen van de Putte EE; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; de Wit R; Beerepoot LV; Verhoeven RH; van Rhijn BW
Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469
[TBL] [Abstract][Full Text] [Related]
64. Impact of increased aspartate aminotransferase to alanine aminotransferase (De Ritis) ratio in prognosis of testicular cancer.
Gorgel SN; Akin Y; Koc EM; Kose O; Ozcan S; Yilmaz Y
Investig Clin Urol; 2019 May; 60(3):169-175. PubMed ID: 31098424
[TBL] [Abstract][Full Text] [Related]
65. The Role of Thrombocyte/Lymphocyte Ratio and Aspartate Transaminase/Alanine Transaminase (De Ritis) Ratio in Prediction of Recurrence and Progression in Non-muscle Invasive Bladder Cancer.
Avcı MA; Arslan B; Arslan O; Özdemir E
Cureus; 2024 Apr; 16(4):e59299. PubMed ID: 38813272
[TBL] [Abstract][Full Text] [Related]
66. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
[TBL] [Abstract][Full Text] [Related]
67. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
[TBL] [Abstract][Full Text] [Related]
68. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
Cai T; Tiscione D; Verze P; Pomara G; Racioppi M; Nesi G; Barbareschi M; Brausi M; Gacci M; Luciani LG; Liguori G; Gontero P; Campodonico F; Simonato A; Boddi V; Di Stasi SM; Colombo R; Serretta V; Carmignani G; Malossini G; Altieri V; Carini M; Terrone C; Bassi P; Montorsi F; Ficarra V; Selli C; Mirone V; Bartoletti R
Urology; 2014 Nov; 84(5):1141-6. PubMed ID: 25239253
[TBL] [Abstract][Full Text] [Related]
69. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
[TBL] [Abstract][Full Text] [Related]
70. Risk factors and outcomes of urethral recurrence following radical cystectomy.
Boorjian SA; Kim SP; Weight CJ; Cheville JC; Thapa P; Frank I
Eur Urol; 2011 Dec; 60(6):1266-72. PubMed ID: 21871713
[TBL] [Abstract][Full Text] [Related]
71. Evaluation of De Ritis (AST/ALT), ALP/ALT, and AST/ALP ratios as prognostic factors in patients with acute ischemic stroke.
Ahmadabad MA; Naeimi A; Keymoradzadeh A; Faghani S; Ahmadabad MA; Boroujeni NA; Mohammadpour H; Saberi A
BMC Neurol; 2022 Dec; 22(1):450. PubMed ID: 36463106
[TBL] [Abstract][Full Text] [Related]
72. The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [
Ruhwedel T; Rogasch JMM; Huang K; Jann H; Schatka I; Furth C; Amthauer H; Wetz C
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562643
[TBL] [Abstract][Full Text] [Related]
73. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy.
Fairey AS; Daneshmand S; Wang L; Schuckman A; Lieskovsky G; Djaladat H; Cai J; Miranda G; Skinner EC
Urol Oncol; 2014 Feb; 32(2):110-6. PubMed ID: 23499168
[TBL] [Abstract][Full Text] [Related]
74. Preoperative hydronephrosis predicts advanced bladder cancer but is not an independent factor for cancer-specific survival after radical cystectomy.
Hofner T; Haferkamp A; Knapp L; Pahernik S; Hadaschik B; Djakovic N; Wagener N; Hohenfellner M
Urol Int; 2011; 86(1):25-30. PubMed ID: 21042001
[TBL] [Abstract][Full Text] [Related]
75. Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy.
Sonpavde G; Khan MM; Svatek RS; Lee R; Novara G; Tilki D; Lerner SP; Amiel GE; Skinner E; Karakiewicz PI; Bastian PJ; Kassouf W; Fritsche HM; Izawa JI; Ficarra V; Dinney CP; Lotan Y; Fradet Y; Shariat SF
BJU Int; 2011 Sep; 108(5):687-92. PubMed ID: 21087453
[TBL] [Abstract][Full Text] [Related]
76. Perioperative management and oncological outcomes following radical cystectomy for bladder cancer: a matched retrospective cohort study.
Weingarten TN; Taccolini AM; Ahle ST; Dietz KR; Dowd SS; Frank I; Boorjian SA; Thapa P; Hanson AC; Schroeder DR; Sprung J
Can J Anaesth; 2016 May; 63(5):584-95. PubMed ID: 26850064
[TBL] [Abstract][Full Text] [Related]
77. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
78. Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage.
Buchner A; Grimm T; Schneevoigt BS; Wittmann G; Kretschmer A; Jokisch F; Grabbert M; Apfelbeck M; Schulz G; Gratzke C; Stief CG; Karl A
Scand J Urol; 2017 Apr; 51(2):130-136. PubMed ID: 28332428
[TBL] [Abstract][Full Text] [Related]
79. The reversed De Ritis ratio for predicting in-hospital mortality among intensive care patients with organophosphate poisoning.
Nafea O; Ibrahim F; Abdelhamid W
Biomarkers; 2023 Feb; 28(1):111-117. PubMed ID: 36377078
[TBL] [Abstract][Full Text] [Related]
80. Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1?
Zargar H; Zargar-Shoshtari K; Lotan Y; Shah JB; van Rhijn BW; Daneshmand S; Spiess PE; Black P;
J Urol; 2016 Apr; 195(4 Pt 1):886-93. PubMed ID: 26521718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]